{"id":"NCT00403260","sponsor":"Medicines for Malaria Venture","briefTitle":"Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients","officialTitle":"A Phase III Comparative, Open-label, Randomised, Multi-centre Study to Assess the Efficacy of Pyronaridine Artesunate (180:60mg) Versus Mefloquine (250mg) Plus Artesunate (100mg) in Children & Adult Patients With Acute Falciparum Malaria","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-01","primaryCompletion":"2008-10","completion":"2008-12","firstPosted":"2006-11-23","resultsPosted":"2021-09-17","lastUpdate":"2021-11-02"},"enrollment":1271,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Falciparum Malaria"],"interventions":[{"type":"DRUG","name":"Pyronaridine - artesunate","otherNames":["Pyramax"]},{"type":"DRUG","name":"Mefloquine plus artesunate","otherNames":[]}],"arms":[{"label":"Pyronaridine - artesunate","type":"EXPERIMENTAL"},{"label":"Mefloquine plus artesunate","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objective of this phase III clinical study is to compare the efficacy and safety of the fixed combination of pyronaridine artesunate (Pyramax®, PA) with that of the combination of mefloquine plus artesunate (MQ + AS) in children and adults with uncomplicated P falciparum malaria in South East Asia, India and Africa.","primaryOutcome":{"measure":"Percentage of Subjects With PCR-corrected Adequate Clinical and Parasitological Response (ACPR) on Day 28","timeFrame":"Day 28","effectByArm":[{"arm":"Pyronaridine - Artesunate","deltaMin":99.2,"sd":null},{"arm":"Mefloquine Plus Artesunate","deltaMin":98.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.106"}]},"eligibility":{"minAge":"3 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":14},"locations":{"siteCount":9,"countries":["Burkina Faso","Cambodia","Côte d’Ivoire","India","Tanzania","Thailand","Vietnam"]},"refs":{"pmids":["22475593","26666916","23433102"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":848},"commonTop":["Headache","Myalgia","Dizziness","Anorexia","Anaemia"]}}